Therapeutic Goods Act 1989
Approval under section 42DF for use of restricted representations by Rhinomed Limited
I, Leanne McCauley, Director, Advertising Compliance Unit, Regulatory Practice, Education and Compliance Branch, and Delegate of the Secretary to the Department of Health, on receipt of an application from Rhinomed Limited, have approved under section 42DF of the Therapeutic Goods Act 1989 (the Act) the restricted representation described in paragraph (a) below for use advertisements directed to consumers, product identified (b):
- 'IMPORTANT: Mute nasal device is not for the treatment of sleep apnea. If you think that your snoring may be a symptom of sleep apnea, you should consult your doctor or a sleep specialist'.
- 'Mute Nasal Device' (ARTG 231158)
Dated this 27th day of April 2016
Signed electronically
Leanne McCauley
Delegate of the Secretary to the Department of Health; and
Director
Advertising Compliance Unit
Regulatory Practice, Education and Compliance Branch